비교리스트

 카트 문의
시장보고서
상품코드
1646724

세계의 테스토스테론 보충 요법(TRT) 시장

Testosterone Replacement Therapy (TRT)
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 406 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 테스토스테론 보충 요법(TRT) 시장은 2030년까지 25억 달러에 도달

2023년에 19억 달러로 추정되는 세계의 테스토스테론 보충 요법(TRT) 시장은 분석 기간인 2023-2030년에 CAGR 4.0%로 성장하며, 2030년에는 25억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 TRT 주사제는 CAGR 4.1%를 기록하며, 분석 기간 종료시에는 16억 달러에 달할 것으로 예측됩니다. TRT 외용제 부문의 성장률은 분석 기간에 CAGR 3.6%로 추정됩니다.

미국 시장은 8억 4,890만 달러로 추정, 중국은 CAGR 5.6%로 성장 예측

미국의 테스토스테론 보충 요법(TRT) 시장은 2023년에 8억 4,890만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 2억 1,930만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년의 CAGR은 5.6%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.2%와 3.8%로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%로 성장할 것으로 예측됩니다.

남성 호르몬 대체요법에 대한 수요를 주도하는 요인은 무엇인가?

테스토스테론 대체요법(TRT)은 성선기능저하증 및 테스토스테론 수치 감소와 관련된 기타 증상으로 고통받는 남성에게 필수적인 치료 옵션이 되었습니다. 테스토스테론은 근육량, 골밀도, 정력,성 건강 유지에 중요한 역할을 하므로 이 호르몬의 감소는 삶의 질에 큰 영향을 미칠 수 있습니다. 세계 인구가 고령화됨에 따라 테스토스테론 결핍증의 유병률이 증가하고 있으며, 이는 TRT에 대한 수요를 주도하고 있습니다. 남성들은 자신의 건강에 대해 더 적극적으로 대처하고 피로, 성욕감퇴, 기분 저하 등의 증상에 대한 의학적 개입을 요구하고 있으며, TRT 솔루션에 대한 관심이 더욱 높아지고 있습니다. 또한 남성 건강 문제에 대한 인식이 높아지고 종합적인 진단 검사가 가능해짐에 따라 테스토스테론 결핍증을 조기에 발견하고 치료할 수 있게 되어 TRT가 남성 헬스케어에 필수적인 요소로 자리 잡게 되었습니다.

전달 시스템의 발전은 TRT의 보급을 어떻게 촉진하고 있는가?

테스토스테론 전달 시스템의 기술적 발전은 TRT 시장에 혁명을 가져왔으며, 치료를 보다 편리하고 효과적이며 환자 친화적으로 만들고 있습니다. 주사나 경구용 정제 같은 전통적인 형태의 TRT는 종종 순응도나 부작용에 대한 문제가 있었습니다. 그러나 경피 패치, 국소 젤, 피하 임플란트와 같은 새로운 전달 방법은 부작용이 적고 안정적인 테스토스테론 수치를 제공합니다. 이러한 혁신은 환자의 순응도와 만족도를 향상시켜 TRT의 채택을 확대하는 데 기여하고 있습니다. 지속형 주사제는 투여 빈도를 줄이고 더 많은 사람들이 치료에 더 쉽게 접근할 수 있도록 도와주어 인기를 끌고 있습니다. 또한 나노테크놀러지과 약물전달 시스템의 발전은 환자 개개인의 생리적 요구에 맞는 치료를 받을 수 있도록 개인화된 TRT 옵션의 길을 열어주고 있습니다.

세계 TRT 시장을 형성하고 있는 동향은?

헬스케어와 소비자 선호도의 변화를 반영하여 몇 가지 동향이 테스토스테론 대체요법 시장을 형성하고 있습니다. 전인적 건강 및 웰빙에 대한 관심이 높아지면서 종합적인 헬스케어의 일환으로 TRT를 찾는 남성이 급증하고 있습니다. 소비자 직접 의뢰(DTC) 원격의료 플랫폼은 대면 진료 없이도 편리하게 진단과 치료 계획을 세울 수 있도록 TRT를 더욱 친숙하게 만들고 있습니다. 생동일성컬 호르몬 대체요법(BHRT)에 대한 관심이 높아진 것도 소비자들이 합성 치료보다 자연적이고 안전한 대체요법을 선호하게된 데 따른 추세입니다. 또한 TRT의 장기적 효과에 대한 연구가 확대되면서 임상의와 환자 모두에게 근거에 기반한 가이드라인이 제공되고 있습니다. 시장은 또한 TRT를 비만 및 심혈관 질환과 같은 관련 질환의 치료와 통합하여 그 효과와 매력을 더욱 높이는 병용 요법 증가를 목격하고 있습니다.

TRT 시장 성장의 원동력은 무엇인가?

테스토스테론 대체요법(TRT) 시장의 성장은 고령화와 생활습관 변화로 인한 성선기능저하증 유병률 증가 등 여러 요인에 의해 주도되고 있습니다. 국소용 젤이나 경피용 패치와 같은 첨단이고 사용하기 쉬운 전달 시스템의 채택이 증가하면서 환자들의 순응도와 만족도가 향상되고 있습니다. 원격의료 플랫폼과 온라인 약국의 보급은 특히 의료 인프라가 부족한 지역에서 TRT에 대한 접근성을 확대하고 있습니다. 활력 유지와 노화 관련 건강 문제 해결에 대한 관심이 높아지면서 더 많은 남성들이 TRT 솔루션을 찾게 되는 등 소비자 행동 동향은 더 많은 남성들이 TRT 솔루션을 찾도록 유도하고 있습니다. 또한 현재 진행 중인 연구개발 노력은 보다 안전하고 효과적인 치료법을 개발하여 새로운 환자를 유치하고 기존 환자를 유지하도록 돕고 있습니다. 새로운 제제의 규제 승인과 신규 진입도 시장 성장에 기여하고 있으며, TRT는 세계 헬스케어 환경의 중요한 컴포넌트로 남아있습니다.

부문

제품 유형(TRT 주사제, TRT 외용제, 기타 제품 유형), 유효 성분(Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone, 기타 유효 성분), 최종사용자(클리닉 최종사용자, 병원 최종사용자)

조사 대상 기업의 예(주목 합계 33사)

  • AbbVie Inc.
  • Acrux Ltd.
  • Besins Healthcare Monaco S.A.M
  • Biote Medical LLC
  • Eli Lilly and Company
  • Endo International plc
  • Ferring International Center S.A.
  • Marius Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 아프리카

제4장 경쟁

KSA 25.02.20

Global Testosterone Replacement Therapy (TRT) Market to Reach US$2.5 Billion by 2030

The global market for Testosterone Replacement Therapy (TRT) estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TRT Injectables, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the TRT Topicals segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$848.9 Million While China is Forecast to Grow at 5.6% CAGR

The Testosterone Replacement Therapy (TRT) market in the U.S. is estimated at US$848.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Testosterone Replacement Therapy (TRT) Market – Key Trends & Drivers Summarized

What Is Driving the Demand for Testosterone Replacement Therapy?

Testosterone replacement therapy (TRT) has become an essential treatment option for men suffering from hypogonadism and other conditions associated with low testosterone levels. As testosterone plays a critical role in maintaining muscle mass, bone density, energy levels, and sexual health, a decline in this hormone can significantly impact quality of life. With the aging global population, the prevalence of testosterone deficiency is increasing, driving demand for TRT. Men are becoming more proactive about their health, seeking medical intervention for symptoms such as fatigue, reduced libido, and mood swings, further propelling interest in TRT solutions. Additionally, the rise in awareness about men’s health issues and the availability of comprehensive diagnostic tests are contributing to early detection and treatment of testosterone deficiencies, solidifying TRT as a vital part of men’s healthcare.

How Are Advancements in Delivery Systems Enhancing TRT Adoption?

Technological advancements in testosterone delivery systems are revolutionizing the TRT market, making treatments more convenient, effective, and patient-friendly. Traditional forms of TRT, such as injections and oral tablets, often posed challenges related to compliance and side effects. However, newer delivery methods, including transdermal patches, topical gels, and subdermal implants, offer steady and consistent testosterone levels with fewer side effects. These innovations have improved patient adherence and satisfaction, contributing to the growing adoption of TRT. Long-acting injectable formulations are also gaining popularity as they reduce the frequency of administration, making the therapy more accessible to a broader demographic. Furthermore, advancements in nanotechnology and drug delivery systems are paving the way for personalized TRT options, ensuring that patients receive treatments tailored to their unique physiological needs.

What Trends Are Shaping the TRT Market Globally?

Several trends are shaping the testosterone replacement therapy market, reflecting the changing landscape of healthcare and consumer preferences. The increasing focus on holistic health and wellness has led to a surge in men seeking TRT as part of their overall health regimen. Direct-to-consumer (DTC) telemedicine platforms are making TRT more accessible, offering convenient diagnosis and treatment plans without the need for in-person visits. The growing interest in bioidentical hormone replacement therapies (BHRT) is another trend, as consumers prefer natural and safer alternatives to synthetic treatments. Additionally, research into the long-term effects of TRT is expanding, providing evidence-based guidance for both clinicians and patients. The market is also witnessing a rise in combination therapies, where TRT is integrated with treatments for related conditions such as obesity and cardiovascular health, further enhancing its efficacy and appeal.

What Factors Are Driving Growth in the TRT Market?

The growth in the testosterone replacement therapy (TRT) market is driven by several factors, including the increasing prevalence of hypogonadism due to aging populations and lifestyle changes. The rising adoption of advanced and user-friendly delivery systems, such as topical gels and transdermal patches, is enhancing patient adherence and satisfaction. The proliferation of telemedicine platforms and online pharmacies is expanding access to TRT, particularly in regions with limited healthcare infrastructure. Consumer behavior trends, such as a growing emphasis on maintaining vitality and addressing age-related health issues, are encouraging more men to seek TRT solutions. Additionally, ongoing research and development efforts are resulting in safer and more effective therapies, attracting new patients and retaining existing ones. Regulatory approvals for novel formulations and the entry of new players in the market are also contributing to its growth, ensuring that TRT remains a key component of the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Testosterone Replacement Therapy (TRT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (TRT Injectables, TRT Topicals, Other Product Types); Active Ingredient (Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone, Other Active Ingredients); End-Use (Clinics End-Use, Hospitals End-Use)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Africa.

Select Competitors (Total 33 Featured) -

  • AbbVie Inc.
  • Acrux Ltd.
  • Besins Healthcare Monaco S.A.M
  • Biote Medical LLC
  • Eli Lilly and Company
  • Endo International plc
  • Ferring International Center S.A.
  • Marius Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Increasing Global Awareness of Hypogonadism and Its Health Implications Drives Widespread Adoption of Testosterone Replacement Therapies
    • Global Economic Update
    • EXHIBIT 1: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 2: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • Competition
    • EXHIBIT 3: Testosterone Replacement Therapy (TRT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Testosterone Replacement Therapy (TRT): A Prelude
    • TRT by Product Type
    • A Comparison of Commonly Prescribed Topical TRT Products
    • List of FDA Approved TRTs by Formulation and Year of Approval
    • Timeline for Launch of Various Types of Testosterone Replacement Therapies
    • Generics Hurt Sales of Branded Drugs
    • Recent Market Activity
    • Influencer/Product/Technology Insights
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advent of Oral Formulations Marks a Transformative Shift in TRT
    • Rising Awareness of Hypogonadism and Its Symptoms Propels Growth in TRT Market
    • EXHIBIT 4: World Hypogonadism Prevalence by Age Group: Percentage of the Disorder in 21-30, 31-40, 41-50, 51-60, 61-70, 71-80, and >80 Age Groups
    • Aging Population and Age-Related Testosterone Decline Expands Addressable Market Opportunity
    • TRT Emerges as an Essential Intervention for Management of Hypogonadis in Adolescents
    • Innovations Addressing Limitations of Traditional Options Spur Growth Opportunities
    • Testosterone Cream Innovations Empower Men to Regain Vitality, Libido & Energy
    • Studies Supporting Cardiovascular Safety of TRT Drugs Buoy Growth Prospects
    • Advances in Hormone Replacement Therapies Propel Development of Novel TRT Products
    • Focus on Personalized Medicine and Tailored TRT Solutions Generates New Market Opportunities
    • Development of Bioidentical Hormones and Natural Alternatives Spurt Interest in TRT
    • Women: A Potential Market for Testosterone Therapy
    • Expansion of Telemedicine and Remote Healthcare Platforms Generates Robust Demand for Convenient At-Home Testosterone Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Testosterone Replacement Therapy (TRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Testosterone Replacement Therapy (TRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for TRT Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for TRT Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for TRT Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for TRT Topicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for TRT Topicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for TRT Topicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Testosterone Cypionate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Testosterone Cypionate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Testosterone Cypionate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Testosterone Undecanoate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Testosterone Undecanoate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Testosterone Undecanoate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Testosterone Enanthate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Testosterone Enanthate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Testosterone Enanthate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Testosterone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Testosterone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Testosterone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Active Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Active Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Active Ingredients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Testosterone Replacement Therapy (TRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Market Analytics
    • TABLE 35: USA Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • TABLE 62: China Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Testosterone Replacement Therapy (TRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Market Analytics
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Testosterone Replacement Therapy (TRT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • TABLE 83: France Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 110: UK Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Testosterone Replacement Therapy (TRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Market Analytics
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • TABLE 167: India Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Testosterone Replacement Therapy (TRT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • TABLE 251: Africa Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Africa Historic Review for Testosterone Replacement Therapy (TRT) by Product Type - TRT Injectables, TRT Topicals and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Africa 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Product Type - Percentage Breakdown of Value Sales for TRT Injectables, TRT Topicals and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 254: Africa Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Africa Historic Review for Testosterone Replacement Therapy (TRT) by Active Ingredient - Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Africa 16-Year Perspective for Testosterone Replacement Therapy (TRT) by Active Ingredient - Percentage Breakdown of Value Sales for Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone and Other Active Ingredients for the Years 2014, 2024 & 2030
    • TABLE 257: Africa Recent Past, Current & Future Analysis for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Africa Historic Review for Testosterone Replacement Therapy (TRT) by End-Use - Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Africa 16-Year Perspective for Testosterone Replacement Therapy (TRT) by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use and Hospitals End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제